Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-03-06 @ 12:27 AM
Study NCT ID:
NCT04265651
Status:
COMPLETED
Last Update Posted:
2025-10-22
First Post:
2020-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Infigratinib in Children With Achondroplasia
Sponsor:
QED Therapeutics, a BridgeBio company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Achondroplasia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Skeletal dysplasia | View |
| None | Endochondral ossification | View |
| None | ACH | View |
| None | Shortened proximal limbs | View |
| None | Fibroblast growth factor receptor 3 | View |
| None | FGFR3 | View |
| None | Endochondral bone formation | View |
| None | Short-limb disproportionate dwarfism | View |
| None | dwarfism | View |
| None | Bone disease | View |
| None | Bone diseases, developmental | View |
| None | Musculoskeletal diseases | View |
| None | Osteochondrodysplasia | View |
| None | Genetic diseases, inborn | View |
| None | Inborn | View |